Camsirubicin

Generic Name: Camsirubicin

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₂₇H_₃₀N_₂O_₁₀

CAS Number: 236095-29-7

Unique Ingredient Identifier: 7W3RB6E22W

Background: GPX-150 has been used in trials studying the treatment of Soft Tissue Sarcoma and Advanced Solid Tumors - Phase 1 Population.

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Camsirubicin + Pegfilgrastim to Determine MTD in ASTS

Phase 1

Terminated

Conditions: Advanced Soft-tissue Sarcoma

Interventions: Drug: Camsirubicin

First Posted Date: 2021-09-14

Last Posted Date: 2024-05-16

Lead Sponsor: Monopar Therapeutics

Target Recruit Count: 14

Registration Number: NCT05043649

Locations: 🇺🇸
Sarcoma Oncology Center, Santa Monica, California, United States
🇺🇸
University of Washington Medicine Fred Hutchinson Cancer Center, Seattle, Washington, United States

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy